INVOX PHARMA LIMITED - Key Persons
Over 25 years' experience in the pharmaceutical industry, the last 16 years leading business development roles in Europe, US, and Canada. Formerly Novartis, Aspen, and Pharmathen.
Twenty years of experience in small molecule and biological drug development in the pharmaceutical industry, working across preclinical and clinical stages. Twelve years in senior leadership roles at AstraZeneca, including head of global disease area teams.
Over 13 years of experience in the biotech/pharmaceutical industry, in a variety of reporting and business partnering roles. Formerly at F-star Therapeutics, AstraZeneca and MedImmune.
Job Titles:
- Chief Technical Officer and Head of RIC
25+ yrs. experience in the development of diagnostics, medical device and combination products from ideation to commercialisation and CDMO for the pharmaceutical and respiratory industry encompassing operations, R&D, programme management and executive leadership positions.
Job Titles:
- Head of InvoX Therapeutic Innovation ( ITI )
15+ years' R&D experience in immuno-oncology and antibody research in biotech and large pharma. Formerly at Cambridge Antibody Technology, Medimmune/AstraZeneca and F-star Therapeutics.
20 years pharmaceutical industry experience in clinical and medical affairs.35+ years as a practicing physician in oncology. Formerly at Bristol-Myers Squibb, Celgene, and Lilly.
Chairwoman of the Board, an executive director, the chairwoman of the executive board committee, and the nomination committee for our parent company, Sino Biopharmaceutical Co., Ltd. since 2015.
More than ten years experience in legal practice and in-house counsel, formerly at Syneos Health.